Showing results (2641-2650 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|October 9, 2025
Deciphering letermovir's mode of action and resistance mutation effectsC Gourin, T Flores, C Lefèvre, et al.Antiviral Research|December 28, 2020
Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio)Meizhen Su, Ruizhe Tang, Hao Wang, et al.Antiviral Research|January 15, 2020
The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccinationElizabeth C Clarke, Steven B BradfuteAntiviral Research|April 2, 2020
Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockadeMargarita-Maria Panou, Michelle Antoni, Ethan L Morgan, et al.Antiviral Research|April 3, 2020
Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitorsRoberto Manganaro, Birgit Zonsics, Lisa Bauer, et al.Antiviral Research|April 5, 2020
An efficient method for simultaneously screening for HIV, syphilis, and HCV based on one dried blood spot sampleJieqiong Ma, Yanan Ren, Lin He, et al.Antiviral Research|April 7, 2020
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitroKa-Tim Choy, Alvina Yin-Lam Wong, Prathanporn Kaewpreedee, et al.Antiviral Research|April 7, 2020
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitroLeon Caly, Julian D Druce, Mike G Catton, et al.Antiviral Research|April 7, 2020
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent miceMarkus Wild, Luca D Bertzbach, Pierre Tannig, et al.Antiviral Research|December 22, 2019
Structure-activity relationships of fluorene compounds inhibiting HCV variantsHee Sun Kim, Youngsu You, Jaegon Mun, et al.Pageof 523